, Volume 180, Issue 3–4, pp 237–243 | Cite as

Successful Treatment of Refractory Majocchi’s Granuloma with Voriconazole and Review of Published Literature

  • H. B. Liu
  • F. Liu
  • Q. T. Kong
  • Y. N. Shen
  • G. X. Lv
  • W. D. Liu
  • H. Sang


Majocchi’s granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.


Majocchi’s granuloma Trichophyton rubrum Bacterial infection Voriconazole 



This work was supported by the Jiangsu Province Postdoctoral Research Finding Schemes (1302032B).


  1. 1.
    Gill M, Sachdeva B, Gill PS, Arora B, Deep A, Karan J. Majocchi’s granuloma of the face in an immunocompetent patient. J Dermatol. 2007;34:702–4.CrossRefPubMedGoogle Scholar
  2. 2.
    Kim JE, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Majocchi’s granuloma mimicking Kaposi sarcoma in a heart transplant patient. J Dermatol. 2011;38:927–9.PubMedGoogle Scholar
  3. 3.
    Radentz WH, Yanase DJ. Papular lesions in an immunocompromised patient. Trichophyton rubrum granulomas (Majocchi’s granuloma). Arch Dermatol. 1993;129(1189–90):92–3.Google Scholar
  4. 4.
    Smith KJ, Welsh M, Skelton H. Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients. Br J Dermatol. 2001;145:344–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Sequeira M, Burdick AE, Elgart GW, Berman B. New-onset Majocchi’s granuloma in two kidney transplant recipients under tacrolimus treatment. J Am Acad Dermatol. 1998;38:486–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Kanaan IC, Santos TB, Kac BK, Souza AM, Cerqueira AM. Majocchi’s granuloma—case report. An Bras Dermatol. 2015;90:251–3.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Kurian A, Haber RM. Tinea corporis gladiatorum presenting as a Majocchi granuloma. ISRN Dermatol. 2011;2011:767589.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Pietrzak A, Tomasiewicz K, Kanitakis J, Paszkowski T, Dybiec E, Donica H, et al. Trichophyton mentagrophytes-associated Majocchi’s granuloma treated with cryotherapy. Folia Histochem Cytobiol. 2012;50:486–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Chang SE, Lee DK, Choi JH, Moon KC, Koh JK. Majocchi’s granuloma of the vulva caused by Trichophyton mentagrophytes. Mycoses. 2005;48:382–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Ratajczak-Stefanska V, Kiedrowicz M, Maleszka R, Rozewicka M, Mikulska D. Majocchi’s granuloma caused by Microsporum canis in an immunocompetent patient. Clin Exp Dermatol. 2010;35:445–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Bae BG, Kim HJ, Ryu DJ, Kwon YS, Lee KH. Majocchi granuloma caused by Microsporum canis as tinea incognito. Mycoses. 2011;54:361–2.CrossRefPubMedGoogle Scholar
  12. 12.
    Gupta AK, Prussick R, Sibbald RG, Knowles SR. Terbinafine in the treatment of Majocchi’s granuloma. Int J Dermatol. 1995;34:489.CrossRefPubMedGoogle Scholar
  13. 13.
    Margolis DJ, Weinberg JM, Tangoren IA, Cheney RT, Johnson BL Jr. Trichophytic granuloma of the vulva. Dermatology. 1998;197:69–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Coelho WS, Diniz LM, Sousa Filho JB, Castro CM. [Case for diagnosis. Granuloma trichophyticum (Majocchi’s granuloma)]. An Bras Dermatol. 2009;84:85–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Bressan AL, Silva RS, Fonseca JC, Alves Mde F. Majocchi’s granuloma. An Bras Dermatol. 2011;86:797–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Li FQ, Lv S, Xia JX. Majocchi’s granuloma after topical corticosteroids therapy. Case Rep Dermatol Med. 2014;2014:507176.PubMedCentralPubMedGoogle Scholar
  17. 17.
    Tateishi Y, Sato H, Akiyama M, Abe M, Kobayashi H, Umehara S, et al. Severe generalized deep dermatophytosis due to Trichophyton rubrum (trichophytic granuloma) in a patient with atopic dermatitis. Arch Dermatol. 2004;140:624–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Collins MA, Lloyd R. Photo quiz. Treatment-resistant plaque on the thigh. Majocchi granuloma. Am Fam Physician. 2011;83:753–4.PubMedGoogle Scholar
  19. 19.
    Hellier FF. Trichophytic granuloma simulating Bazin’s disease. Br Med J. 1962;2:644–5.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Chen HH, Chiu HC. Facial Majocchi’s granuloma caused by Trichophyton tonsurans in an immunocompetent patient. Acta Derm Venereol. 2003;83:65–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Molina-Leyva A, Perez-Parra S, Garcia-Garcia F. Case for diagnosis. An Bras Dermatol. 2014;89:839–40.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Cho HR, Lee MH, Haw CR. Majocchi’s granuloma of the scrotum. Mycoses. 2007;50:520–2.CrossRefPubMedGoogle Scholar
  23. 23.
    Feng WW, Chen HC. Majocchi’s granuloma in a 3-year-old boy. Pediatr Infect Dis J. 2006;25:658–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Gupta AK, Groen K, Woestenborghs R, De Doncker P. Itraconazole pulse therapy is effective in the treatment of Majocchi’s granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol. 1998;23:103–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Romero FA, Deziel PJ, Razonable RR. Majocchi’s granuloma in solid organ transplant recipients. Transpl Infect Dis. 2011;13:424–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Steiner UC, Trueb RM, Schad K, Kamarashev J, Koch S, French LE, et al. Trichophyton rubrum-induced Majocchi’s granuloma in a heart transplant recipient. A therapeutic challenge. J Dermatol Case Rep. 2012;6:70–2.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Stoppie P, Borghgraef P, Borgers M. Cutaneous distribution of orally administered itraconazole in guinea pigs, studied by autoradiography. J Eur Acad Dermatol Venereol. 1994;3:475–8.CrossRefGoogle Scholar
  28. 28.
    Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.CrossRefPubMedGoogle Scholar
  29. 29.
    Ally R, Schurmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis. 2001;33:1447–54.CrossRefPubMedGoogle Scholar
  30. 30.
    Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs. 2007;67:269–98.CrossRefPubMedGoogle Scholar
  31. 31.
    Carrillo-Munoz AJ, Giusiano G, Guarro J, Quindos G, Guardia C, del Valle O, et al. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents. 2007;30:157–61.CrossRefPubMedGoogle Scholar
  32. 32.
    Ghannoum M, Isham N, Sheehan D. Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol. 2006;44:2579–80.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther. 2003;25:1321–81.CrossRefPubMedGoogle Scholar
  34. 34.
    Weiler S, Fiegl D, MacFarland R, Stienecke E, Bellmann-Weiler R, Dunzendorfer S, et al. Human tissue distribution of voriconazole. Antimicrob Agents Chemother. 2011;55:925–8.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • H. B. Liu
    • 1
  • F. Liu
    • 1
  • Q. T. Kong
    • 1
  • Y. N. Shen
    • 2
  • G. X. Lv
    • 2
  • W. D. Liu
    • 2
  • H. Sang
    • 1
  1. 1.Jinling Hospital, Department of DermatologyNanjing University, School of MedicineNanjingPeople’s Republic of China
  2. 2.Institute of Dermatology, Chinese Academy of Medical SciencesPeking Union Medical CollegeNanjingPeople’s Republic of China

Personalised recommendations